Though TfRMAb-TNFR resulted in an innate immune response (TREM2-positive microglial clustering) towards the β-sheet-rich Aβ plaques in the 3xTg-AD mice, we did not see significant changes in tau phosphorylation with the treatment. This evidence concerns the gene TREM2 and Alzheimer disease.